Recursion Pharmaceuticals
Piotr Stepien is a Senior Scientist III and team leader in Immuno-Oncology at Recursion since November 2024, previously holding similar roles at Exscientia from February 2021 to November 2024, and has progressed through various positions including Research Scientist and In vitro Pharmacologist at Selvita between November 2017 and January 2021. Academic background includes a Magister in Biotechnologia Medyczna from Śląska Akademia Medyczna w Katowicach (2015-2017) and a Licencjat in Biotechnologia from Uniwersytet Marii Curie-Skłodowskiej w Lublinie (2012-2015). Early experience includes visiting master student roles at both Dana-Farber Cancer Institute and the University of Oxford in 2017 and 2016, respectively.
This person is not in any teams
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.